Menú
  • Home
  • USR Unitat Transversal de Recerca

USR Unitat Transversal de Recerca

avatar_grups_recerca.png

Projectes

Group projects

Post-Authorisation Safety Study of Comirnaty Original/Omicron BA.1 and Comirnaty Original/Omicron BA.4-5 in Europe

  • Principal investigators: Felipe Villalobos Martínez
  • Code: 4RNC-0-00063-24
  • Start year: 2024

A framework for the post-authorisation safety monitoring and evaluation of vaccines in the EU: Study protocol for the occurrence of flares of Graves´ disease, Hashimoto´s thyroiditis, polyarteritis nodosa, autoimmune hepatitis, rheumatoid arthritis, psoriatic arthritis, multiple sclerosis, erythema nodosum, systemic lupus erythematosus, and ulcerative colitis using electronic healthcare data sources.

  • Principal investigators: Felipe Villalobos Martínez
  • Code: 4RNC-0-00194-24
  • Start year: 2024
  • Funders: European Medicines Agency (EMA)

Body size and risk of development of 22 major cancers: Data from the Information System for the Development of Research in Primary Care collected on 6 million Catalans

  • Principal investigators: Talita Duarte Salles
  • Code: 4R17/074
  • Start year: 2017
  • Funders: WCRF NL Stichting Wereld Kanker Onderzoek Fonds

Síndrome metabólico y riesgo de cáncer: estudio caso-control con datos del Sistema de Información para el Desarrollo de la Investigación en Atención Primaria (SIDIAP) en Cataluña

  • Principal investigators: Diana Puente Baliarda
  • Code: 4R17/078
  • Start year: 2017
  • Funders: Instituto de Salud Carlos III

European Non-interventional Post Authorization Safety Study for romosozumab by the EU-ADR Alliance

  • Principal investigators: Talita Duarte Salles, Carlen Reyes Reyes
  • Code: 4R18/149
  • Start year: 2018